Receives Gold Rating as part of BSV ART Act Readiness Assessment Programme
Bharat Serums and Vaccines Limited (BSV) a leading biopharmaceutical company in India, along with Bureau Veritas (India) Pvt Ltd (BVIL), a world leader in Audit and Certification Services, has put together a first-of-its-kind BSV ART Act Readiness Programme. Through this programme, BVIL will assess IVF centres/clinics and help them implement the requirements of the Assisted Reproductive Technology Regulations, 2021 (the ART Act). Through an intensive survey, BVIL has assessed and certified Umadevi Sitaram Bairagi Hospital Fertility & Research Centre with a Gold Rating.
Alok Khettry, COO, India Business , BSV said, “ Keeping the patient at the core of all that we do, the BSV ART Act Readiness Assessment Programme endeavours to support IVF centres/ clinics to improve safety and provide ethical practices related to assisted reproductive technology services. We are delighted that Uma Fertility has been awarded a Gold Rating by ‘Bureau Veritas’ which is testimony to their robust processes and standards. The centre has been assessed on six critical parameters: infrastructure; people and competency management; communication; patient and process selection; data records and compliance monitoring. We are confident that this Assessment will ready Uma Fertility to transform into a model centre as described in the Act.”
Dr Sainath Bairagi, Gynaecologist & Sr IVF specialist, Umadevi Sitaram Bairagi Hospital Fertility & Research-Centre, added “This Gold Rating validates our patient-centric approach and high ethical standards that form the purpose of our existence, which has always been to serve humanity in every way. It is a moment of pride for the entire team of Uma Fertility to be a part of a first-of-its-kind validation process and we are delighted to have received this unique distinction that demonstrates the highest standards of service levels while ensuring adherence to safe and ethical practice of ART services.”
The BSV ART Act Readiness Program is an industry initiative that aims to assess 50+ IVF centres/clinics (in the first six months) support the clinics in their readiness for the Assisted Reproductive Technology Regulations, 2021 (the ART Act), and support them in their journey of excellence in customer service.
